PCLS Acquires MultiGen Dx Assets | GenomeWeb

NEW YORK (GenomeWeb News) – Specialty laboratory Physician's Choice Laboratory Services today announced it has acquired the assets of MultiGen Diagnostics for an undisclosed amount.

The deal includes full access to and control of the commercialization of MultiGen's platform technology, which PCLS said "greatly reduces the cost of delivering targeted molecular diagnostics and genetic mutation analysis."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.